Citrasate® The Future of Dialysis Concentrates
At SHK Medical, Citrasate® is more than just a concentrate—it’s a promise of safer treatments and enhanced patient care. The same high‐quality standards that the leading global dialysis brands use. Citrate-based solution minimises the need for heparin and maximises treatment efficiency. A product developed and created in the USA. USFDA registered product.
Join us on a journey to make every dialysis session a step towards a healthier tomorrow
Experience a breakthrough in dialysis treatment with Citrasate®. Our clinically proven citrate‐based formula reduces heparin use by up to 55%, enhances dialysis efficiency, and slashes operating costs—while maintaining the uncompromised quality trusted by the top three global dialysis brands. Discover a product engineered for precision, safety, and superior performance.
Citrasate® is a clinically proven citrate-based dialysis concentrate designed to enhance patient well-being while significantly reducing operating costs for clinics. Compared to traditional acetic acid-based dialysates, Citrasate® offers superior anticoagulation, fewer infections, and lower drug dependency—leading to safer, more efficient dialysis sessions. All achieved with a LOWER COST than your current liquid concentrate.
1. Advanced Anticoagulation – Less Heparin, Safer Treatment
Up to 55% Reduction in Heparin Usage Clinical studies confirm that Citrasate® can lower or even eliminate the need for heparin, making it ideal for patients with a high bleeding risk.
No Clotting Complications Unlike traditional dialysates, Citrasate® maintains optimal blood flow while reducing excessive bleeding episodes
4. Reduced Nursing Time & Drug Use
Fewer infections mean less nursing intervention.
Lower heparin dependency reduces overall medication costs.
Less inflammation leads to improved patient well-being and fewer complications
3. Cost Savings – Lower OperatingExpenses for Clinics
Shipping & Storage Efficiency
1200 treatment sessions fit in the same space as 220 liquid treatment sessions, drastically reducing shipping costs and storage space.
Clinics benefit from lower transportation expenses and simplified logistics.
2. Enhanced Dialysis Efficiency – Better Toxin Removal
Improved Dialysis Dose (Kt/V) Citrasate® keeps dialyzer fibres and pores open, boosting urea reduction and overall treatment efficacy.
Optimized Patient Recovery Patients experience fewer post-dialysis complications, leading to smoother, safer recovery
More Energy, Fewer Complications
Reduced Infection Rates Citrasate® supports better immune response, leading to fewer dialysis-related infections.
Lower Inflammation & Faster Recovery Patients report improved energy levels and less post-dialysis fatigue.
Better Overall Well-Being With over 30 years of clinical studies, Citrasate® has consistently demonstrated positive patient outcomes worldwide *
1200 Sessions of Dry Citrasate® Concentrate
No 55 Gallon Drums
No Drum Pump-Off
No Product Wasted
Valuable Storage Space Created
1 Container shipment of
15,000 sessions of Citrasate® Part A & B
220 Sessions of liquid Acid Concentrate (A)
55 Gallon Drums Take up Space
Drum Pump-Off Required
Product Wasted from Drum Pump-Off
Valuable Storage Space Wasted
8 Container shipments for equivalent of Dry Citrasate® Part A & B